Götschi, Andrea

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

Journal Article

Ciurea, Adrian; Götschi, Andrea; Bräm, René; Bürki, Kristina; Exer, Pascale; Andor, Michael; Nissen, Michael J; Möller, Burkhard; Hügle, Thomas; Rubbert-Roth, Andrea; Kyburz, Diego; Distler, Oliver; Scherer, Almut; Micheroli, Raphael (2023). Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry. RMD open, 9(4) BMJ Publishing Group 10.1136/rmdopen-2023-003455

Barco, Stefano; Virdone, Saverio; Götschi, Andrea; Ageno, Walter; Arcelus, Juan I; Bingisser, Roland; Colucci, Giuseppe; Cools, Frank; Duerschmied, Daniel; Gibbs, Harry; Fumagalli, Riccardo M; Gerber, Bernhard; Haas, Sylvia; Himmelreich, Jelle C L; Hobbs, Richard; Hobohm, Lukas; Jacobson, Barry; Kayani, Gloria; Lopes, Renato D; MacCallum, Peter; ... (2023). Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials. Thrombosis research, 230, pp. 27-32. Elsevier 10.1016/j.thromres.2023.08.009

Ensslin, Caroline; Micheroli, Raphael; Kissling, Seraphina; Götschi, Andrea; Bürki, Kristina; Bräm, René; de Hooge, Manouk; Baraliakos, Xenofon; Nissen, Michael J; Möller, Burkhard; Exer, Pascale; Andor, Michael; Distler, Oliver; Scherer, Almut; Ciurea, Adrian (2023). Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years. RMD open, 9(3) BMJ Publishing Group 10.1136/rmdopen-2023-003340

Voci, Davide; Götschi, Andrea; Held, Ulrike; Bingisser, Roland; Colucci, Giuseppe; Duerschmied, Daniel; Fumagalli, Riccardo M; Gerber, Bernhard; Hasse, Barbara; Keller, Dagmar I; Konstantinides, Stavros V; Mach, François; Rampini, Silvana K; Righini, Marc; Robert-Ebadi, Helia; Rosemann, Thomas; Roth-Zetzsche, Stéphanie; Sebastian, Tim; Simon, Noemi R; Spirk, David; ... (2023). Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial. Thrombosis research, 221, pp. 157-163. Elsevier 10.1016/j.thromres.2022.10.021

Barco, Stefano; Voci, Davide; Held, Ulrike; Sebastian, Tim; Bingisser, Roland; Colucci, Giuseppe; Duerschmied, Daniel; Frenk, André; Gerber, Bernhard; Götschi, Andrea; Konstantinides, Stavros V; Mach, François; Robert-Ebadi, Helia; Rosemann, Thomas; Simon, Noemi R; Spechbach, Hervé; Spirk, David; Stortecky, Stefan; Vaisnora, Lukas; Righini, Marc; ... (2022). Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet. Haematology, 9(8), e585-e593. Elsevier 10.1016/S2352-3026(22)00175-2

This list was generated on Fri Mar 29 07:52:56 2024 CET.
Provide Feedback